Lia Mix
Founder of Delphi and IHPI, bringing deep reimbursement and policy experience in psychedelic-assisted therapy and commercial health plan strategy.
Team, board, and allies
IHPI brings together leadership experience across commercial health plans, addiction medicine, federal health policy, outcome-based financing, publications, and implementation.
Founder of Delphi and IHPI, bringing deep reimbursement and policy experience in psychedelic-assisted therapy and commercial health plan strategy.
Supports operating cadence, governance execution, and infrastructure for the institute.
Marine Corps combat veteran and policy advocate focused on veteran access, moral injury, and responsible psychedelic therapy policy.
Supports capital formation, funder strategy, and partnership development for the launch phase.
Supports publications, evidence translation, and public-facing resources.
Supports analysis, strategic framing, and decision-support materials for the launch phase.
Board and advisors
Board members
Former Deputy Director for Demand Reduction at the White House Office of National Drug Control Policy; past president and Distinguished Fellow of the American Society of Addiction Medicine.
Veteran, former Acting Assistant Secretary for Health and Chief Medical Officer in the Office of the Assistant Secretary for Health at HHS, with behavioral health and substance-use policy leadership.
Founder of Quantified Ventures and CEO of Quantified Ventures Holdings, known for outcomes-based financing models that help governments and payers pay for results.
Advisors
Advisor supporting policy development, stakeholder translation, and readiness materials for decision-maker use.
Founder of NorthStar Behavioral Health Advisory, with experience in payer contracting, SUD strategy, operational efficiency, and addiction payment reform.
Policy consultant, scholar, and educator focused on mental health, substance use, psychedelic therapies, public health, and evidence-informed governance.
Clinical and research psychologist with ibogaine and 5-MeO-DMT expertise, advising on evidence, protocols, and trauma-informed implementation.
Strategic allies
IHPI is developing partnerships with recognized bodies including the United Nations Global Mental Health Task Force and similar organizations that can help convene serious decision-makers.
Partnerships are treated as accelerators for distribution and legitimacy. IHPI retains publication control, role clarity, and neutral technical framing.
Work with IHPI